number of downloads : ?
File
language
eng
Attribute
Review
Author
Description
Mesenchymal stem cells (MSCs) have many function, including immunomodulatory activity, tissuerepair capability and regeneration of bone, cartilage and fatty tisssues. MSC culture methods have been established, and safety can be ensured, so MSCs have been applied clinically to treatment of numerous diseases. With respect to hematological diseases, MSC treatment is expected to be effective for therapy-resistant acute graft-versus-host disease (GVHD). In addition, MSCs have been applied to areas such as treatment of chronic GVHD, prevention of GVHD, promotion of hematopoietic stem cell engraftment, and treatment of refractory aplastic anemia. However, on the basis of the cellular characteristics of MSCs, the potential for problems such as increase in relapse, exacerbation of infection, and cancer development must be borne in mind. This article review the current status of, issues with clinical applications to hematological diseases of MSCs.
Subject
mesenchymal stem cell
hematological disease
graft versus host disease
Journal Title
Shimane Journal of Medical Science
Volume
36
Issue
1
Start Page
1
End Page
10
ISSN
03865959
ISSN(Online)
24332410
Published Date
2019-06
NCID
AA00841586
Publisher
Faculty of Medicine, Shimane University
Publisher Aalternative
島根大学医学部
NII Type
Departmental Bulletin Paper
Format
PDF
Rights
Faculty of Medicine, Shimane University
Text Version
出版社版
OAI-PMH Set
Faculty of Medicine